GEN Exclusives

More »

GEN News Highlights

More »
Apr 28, 2009

Duke University to Use WaferGen’s Real-Time PCR System to Validate Cancer SNPs

  • Duke University Medical Center scientists inked a research collaboration to use WaferGen Biosystems SmartChip™ Real-Time PCR System in cancer-related genotyping.  WaferGen believes the SmartChip Real-Time PCR System will be the first platform to combine the high-throughput capability and cost efficiencies of existing microarrays with the sensitivity and accuracy of real-time PCR. 

    Under terms of the collaboration, the laboratory of John A. Olson Jr., M.D., Ph.D., and Jeffrey R. Marks, Ph.D., at the Institute for Genome Sciences and Policy will conduct genotyping projects using the technology to validate SNPs related to breast cancer.  Additionally, researchers will aim to examine the impact the validated SNPs have on patients’ disease prognosis and response to treatment.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?